logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

WuXi Biologics (02269.HK) issued a total of 4.52 million shares due to the exercise of options.

date
11/11/2025
The Seeking Alpha App news reported that WuXi Biologics (02269.HK) announced that a total of 4.52 million shares were issued on November 11, 2025 due to the exercise of options.
Latest
3 m ago
US stocks surged | Xpeng Motors (XPEV.US) continued to rise by over 4% for two trading days, accumulating a total increase of 20%, reaching a new high for the year.
3 m ago
The labor market is showing signs of weakening, with JPMorgan betting on the Bank of England cutting interest rates in December.
4 m ago
Berkshire Hathaway Company rose by 0.1%. The CEO of the company, Warren Buffett, stated on Tuesday that he will increase his lifetime donation and stop writing annual letters to shareholders after stepping down, while retaining a significant amount of Berkshire shares during the transition to Greg Abel.
4 m ago
According to the AI Flash News, Huayuan Securities released a research report on November 11th, giving Haitai Xinguang (688677.SH) a "buy" rating. The reasons for the rating mainly include: 1) High growth in revenue from medical endoscopes and optical business, with the potential of maintenance business gradually being released; 2) Steady improvement in gross profit margin, and overseas expansion opening up new space. (Daily Economic News)
4 m ago
Google executive Justin Stut reports that there are no subsidies from the German government for data centers.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.